01—Abstract
Summary
Summary of the 8-K filed February 17, 2026. Cited figures are marked; the original filing is the authoritative source.
Somnigroup International Inc. (NYSE: SGI) furnished an updated investor presentation on February 17, 2026 under Item 7.01 of Form 8-K.
The presentation is furnished rather than filed, and it is meant for use in investor meetings. It covers fourth-quarter and full-year 2025 results, 2026 outlook, long-term targets, and capital structure, all of which follow the company's February 17, 2026 press release and earnings call. Fourth-quarter 2025 net sales were $1,868 milliona, up 54.7% from $1,208 million, and full-year 2025 net sales were $7,477 million, up 51.6% from $4,931 million.
Fourth-quarter adjusted EBITDA rose 58.8% to $349 millionb, and full-year adjusted EBITDA rose 41.4% to $1,306 million. Full-year GAAP EPS declined 14.8% to $1.84, while full-year adjusted EPS rose 5.9% to $2.70. The presentation attributes the top-line growth to the Mattress Firm acquisition, which closed on February 5, 2025.
For 2026, the company expects adjusted EPS of $3.00 to $3.40c, sales of about $7.9 billion at the midpoint, and adjusted EBITDA of $1.45 billion. It targets mid-single-digit sales compound annual growth from 2025 to 2028 and adjusted EPS of approximately $5.15 by 2028.
Leverage was 3.21xd at December 31, 2025, above the 2.0x to 3.0x target range the company expects to return to. The company plans to allocate about 50 percent of 2026 free cash flow to dividends and share repurchases.
02—Key points
Key Highlights
- Fourth-quarter 2025 net sales were $1,868 million, up 54.7% from $1,208 million; full-year net sales were $7,477 million, up 51.6% from $4,931 million.
- Fourth-quarter adjusted EBITDA was $349 million, up 58.8%; full-year adjusted EBITDA was $1,306 million, up 41.4%.
- Full-year GAAP EPS fell 14.8% to $1.84, while full-year adjusted EPS rose 5.9% to $2.70.
- 2026 guidance calls for adjusted EPS of $3.00 to $3.40, sales of about $7.9 billion at the midpoint, and adjusted EBITDA of $1.45 billion, with gross margin slightly above 45%.
- Long-term target is mid-single-digit sales growth from 2025 to 2028, with adjusted EPS of approximately $5.15 by 2028, a compound annual growth rate of 24%.
- Leverage was 3.21x at December 31, 2025, with liquidity of about $774 million; the company expects to return to its 2.0x to 3.0x target range.
- Mattress Firm net synergies are targeted at $95 million in 2026 and $50 million in 2027, on top of $80 million realized in 2025, for $225 million in total.
03—Questions
Frequently Asked Questions
How did Somnigroup perform in fourth-quarter and full-year 2025?
Fourth-quarter net sales were $1,868 million, up 54.7%, and net income was $141 million, up 95.8%. Full-year net sales were $7,477 million, up 51.6%, while full-year net income was $384 million, down 0.1% from the prior year. Fourth-quarter adjusted EPS was $0.72 versus $0.60 a year earlier.
What is the company's 2026 outlook?
The company expects full-year adjusted EPS of $3.00 to $3.40, sales of about $7.9 billion at the midpoint, and adjusted EBITDA of $1.45 billion. It also expects a gross margin slightly above 45%, about $720 million of advertising investment, depreciation and amortization of $315 million, capital expenditures of $250 million, interest expense of $225 million, and 214 million diluted shares.
What are the long-term targets?
The company is targeting mid-single-digit sales compound annual growth between 2025 and 2028. It indicates adjusted EPS would rise from $2.70 in 2025 to approximately $5.15 by 2028, a compound annual growth rate of 24%.
How leveraged is the company, and how will it use cash?
Leverage was 3.21x at December 31, 2025, and liquidity was about $774 million. The company expects to return to its 2.0x to 3.0x target range. It intends to allocate about 50 percent of 2026 free cash flow to dividends and share repurchases. Credit ratings are BB+ from Fitch, Ba2 from Moody's, and BB from S&P.
What is the status of the Mattress Firm integration?
The Mattress Firm acquisition closed on February 5, 2025. Net synergies are expected to total $225 million on an adjusted EBITDA basis, with $80 million realized in 2025, a $95 million target for 2026, and a $50 million target for 2027. Sales synergies were $60 million in 2025 and are targeted at $40 million to $100 million in 2026 and 2027.
04—Continue